Sigilon Therapeutics Inc. is a cutting-edge biotechnology company specializing in the development of cell therapies for chronic diseases. With a focus on creating living therapeutics, the company aims to revolutionize the treatment of conditions such as hemophilia, diabetes, and cancer. Led by a team of experienced scientists, Sigilon Therapeutics is at the forefront of medical innovation.
- Latest
- Trending
